Cloud Zoom small image
˂
˃

PAXUS


ការពិពណ៍នា:

PAXUS

 Paxus injection USP 100mg/16.7ml has Plant Cell Culture (PCC) Technology

Composition

- Paclitaxel Injection USP 100mg/16.7mL

Indication:

PAXUS is indicated:
  • ​As first line and subsequent therapy for the treatment of
     advanced carcinoma of the ovary. As first line therapy PAXUS is
     indicated in combination with cisplatin.
 •​ For the treatment of breast cancer after failure of combination
    ​chemotherapy for metastatic disease or relapse within 6 months
​​​​    of adjuvant chemotherapy. Prior therapy should have
    anthracycline unless clinically contraindicated.


ចែកចាយ